624 Results
Guidelines and Advice
Status: Current
Apr 2017
Guidelines and Advice
Status: Current
ID: GL-C50-24
Version: 3
ID: GL-C50-24
Version: 3
Jan 2024
Guidelines and Advice
Status: Current
ID: GL-C50-32
ID: GL-C50-32
Jan 2021
Guidelines and Advice
Status: Archived
ID: 43096
ID: 43096
Feb 2018
Guidelines and Advice
Symptom Management
Symptom Management
Symptom Management
Symptom Management
Drug
Oct 2023
Drug
Other Name(s): Neulasta®
, Lapelga™
, Fulphila™
, Ziextenzo®
, Nyvepria™
Dec 2022